A5048042496- Bladder and Urothelial Cancer Treatments
- Renal cell carcinoma treatment
- Renal and related cancers
- Urinary and Genital Oncology Studies
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urological Disorders and Treatments
- Testicular diseases and treatments
- Adrenal and Paraganglionic Tumors
- Cancer Genomics and Diagnostics
- Sarcoma Diagnosis and Treatment
- Pituitary Gland Disorders and Treatments
- Cancer, Hypoxia, and Metabolism
- Cancer Immunotherapy and Biomarkers
- Hormonal Regulation and Hypertension
- Multiple and Secondary Primary Cancers
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Urinary Bladder and Prostate Research
- Urologic and reproductive health conditions
- Genital Health and Disease
- Genetic factors in colorectal cancer
- Pancreatic and Hepatic Oncology Research
- Esophageal Cancer Research and Treatment
- Economic and Financial Impacts of Cancer
- Radiomics and Machine Learning in Medical Imaging
Medical University of Graz
2019-2025
Université de Montréal
2023-2025
McGill University Health Centre
2023-2024
Cytodiagnostics (Canada)
2024
European Institute of Oncology
2023
Federico II University Hospital
2023
Vita-Salute San Raffaele University
2023
Istituti di Ricovero e Cura a Carattere Scientifico
2023
Urologic Research Institute
2023
Universität Hamburg
2023
Abstract To test for rates of inpatient palliative care (IPC) in metastatic testicular cancer patients receiving critical therapy (CCT). Within the Nationwide Inpatient Sample (NIS) database (2008–2019), we tabulated IPC CCT, namely invasive mechanical ventilation (IMV), percutaneous endoscopic gastrostomy tube (PEG), dialysis acute kidney failure (AKF), total parenteral nutrition (TPN) or tracheostomy. Univariable and multivariable logistic regression models addressing were fitted. Of 420...
Introduction: We aimed to test the impact of International Society Urological Pathology (ISUP) grade group (GG) on cancer-specific mortality (CSM) in organ-confined (pT2) prostate cancer (PCa) at radical prostatectomy (RP). Methods: RP patients were identified (Surveillance, Epidemiology, and End Results 2004−2015). Cancer-specific survival (CSS) rates tested Kaplan-Meier plots multivariable Cox regression (MCR) models according GG: 1–3 vs. 4 5. Sensitivity analyses addressed GG4 GG5 with...
Background: It is unknown whether more complex UD, such as orthotopic neobladder and abdominal pouch, may be associated with higher OCM rates than ileal conduit. We addressed this knowledge gap within the SEER database 2004–2020. Methods: All T1-T4aN0M0 radical cystectomy (RC) patients were identified. After 1:1 propensity score matching (PSM), cumulative incidence plots, univariable multivariable competing-risks regression (CRR) models used to test differences in according UD type...
Background/Aim: The Aspartate aminotransaminase/Alanine aminotransaminase ratio (AST/ALT ratio) has been identified as a prognostic marker for several malignancies. In this study, we evaluated the value of AST/ALT in large cohort non-metastatic colorectal cancer patients (CRC). Patients and Methods: A total 536 with stage II III CRC, well available were included single-center retrospective analysis. Laboratory data measured within two weeks before histological tumor diagnosis. Co-Primary...
This study aimed to test for temporal trends of in-hospital venous thromboembolism (VTE) and pulmonary embolism (PE) after major urologic cancer surgery (MUCS).In the Nationwide Inpatient Sample (NIS) database (2010-2019), this identified non-metastatic radical cystectomy (RC), prostatectomy (RP), nephrectomy (RN), partial (PN) patients. Temporal VTE PE multivariable logistic regression analyses (MLR) addressing or PE, mortality with were performed.Of 196,915 patients, 1180 (1.0%) exhibited...
Background It is unknown whether 5‐year overall survival (OS) differs and to what extent between the American Joint Committee on Cancer stage III non‐seminoma testicular germ cell tumor (NS‐TGCT) patients simulated age‐matched male population‐based controls, according race/ethnicity groups. Methods We identified newly diagnosed (2004–2014) NS‐TGCT within Surveillance Epidemiology End Results database 2004–2019. For each case, we an control (Monte Carlo simulation), relying Social Security...
Within the Surveillance, Epidemiology, and End Results database (2000–2019), we identified 5522 unilateral surgically treated non-metastatic chromophobe kidney cancer (chRCC) patients. This population was randomly divided into development vs. external validation cohorts. In cohort, original Leibovich 2018 GRANT categories were applied to predict 5- 10-year cancer-specific survival (CSS). Subsequently, a novel multivariable nomogram developed. Accuracy, calibration decision curve analyses...
Guidelines recommend VENUSS and GRANT models for the prediction of cancer control outcomes after nephrectomy nonmetastatic papillary renal cell carcinoma (pRCC).To test ability to predict 5-yr cancer-specific survival in a North American population.For this retrospective study, we identified 4184 patients with unilateral surgically treated pRCC Surveillance, Epidemiology, End Results database (2004-2019).The original risk categories were applied survival. A cross-validation method was used...
Purpose To assess whether 5‐year overall survival (OS) of squamous cell carcinoma the penis (SCCP) patients differs from age‐matched male population‐based controls. Methods We relied on Surveillance Epidemiology and End Results database (2004–2018) to identify newly diagnosed (2004–2013) SCCP patients. For each case, we simulated an control (Monte Carlo simulation), relying Social Security Administration (SSA) Life Tables with 5 years follow‐up. compared OS between controls in a...
Abstract Objective To test the ability of 2015 modified version European Network for Study Adrenal Tumors staging system (mENSAT) in predicting cancer-specific mortality (CSM), as well overall (OM) adrenocortical carcinoma (ACC) patients all stages, a large-scale, and contemporary United States cohort. Methods We relied on Surveillance, Epidemiology, End Results (SEER) database (2004–2020) to accuracy calibration mENSAT subsequently compared it 8th edition American Joint Committee Cancer...